PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
39.51
-1.14 (-2.80%)
May 6, 2025, 12:34 PM EDT - Market open
PTC Therapeutics Employees
PTC Therapeutics had 939 employees as of December 31, 2024. The number of employees decreased by 116 or -11.00% compared to the previous year.
Employees
939
Change (1Y)
-116
Growth (1Y)
-11.00%
Revenue / Employee
$859,191
Profits / Employee
-$386,896
Market Cap
3.12B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PTCT News
- 19 hours ago - Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal? - Benzinga
- 1 day ago - PTC518 PIVOT-HD Study Achieves Primary Endpoint - PRNewsWire
- 4 days ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 11 days ago - PTC Therapeutics Receives Positive CHMP Opinion for Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) - PRNewsWire
- 12 days ago - PTC Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 19 days ago - PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - PTC Therapeutics Shares Fall After EU Drops Translarna Authorization - Market Watch
- 5 weeks ago - PTC Therapeutics says European Commission will remove muscle disorder drug - Reuters